BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27229525)

  • 1. The Long-Term Safety of S-Flurbiprofen Plaster for Osteoarthritis Patients: An Open-Label, 52-Week Study.
    Yataba I; Otsuka N; Matsushita I; Matsumoto H; Hoshino Y
    Clin Drug Investig; 2016 Aug; 36(8):673-82. PubMed ID: 27229525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of S-flurbiprofen plaster in knee osteoarthritis treatment: Results from a phase III, randomized, active-controlled, adequate, and well-controlled trial.
    Yataba I; Otsuka N; Matsushita I; Matsumoto H; Hoshino Y
    Mod Rheumatol; 2017 Jan; 27(1):130-136. PubMed ID: 27168463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A minimal impact of long-term S-flurbiprofen plaster application on kidney function in osteoarthritis patients.
    Otsuka N; Yataba I; Matsushita I; Matsumoto H; Hoshino Y; Terada Y
    Clin Exp Nephrol; 2017 Dec; 21(6):1060-1067. PubMed ID: 28378068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of S-flurbiprofen plaster in knee osteoarthritis patients: A 2-week randomized controlled Phase III clinical trial compared to diclofenac gel.
    Tomatsu K; Yasuda S; Fuady A; Matsumoto H; Sumariyono
    Int J Rheum Dis; 2022 May; 25(5):563-570. PubMed ID: 35199483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma pharmacokinetics and synovial concentrations of S-flurbiprofen plaster in humans.
    Yataba I; Otsuka N; Matsushita I; Kamezawa M; Yamada I; Sasaki S; Uebaba K; Matsumoto H; Hoshino Y
    Eur J Clin Pharmacol; 2016 Jan; 72(1):53-9. PubMed ID: 26438533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of efficacy and safety in the combination therapies of duloxetine and S-flurbiprofen plaster, and of duloxetine and conventional NSAIDs for chronic pain in patients with osteoarthritis (OASIS DUAL study).
    Koyama K
    Drug Discov Ther; 2022 Nov; 16(5):217-224. PubMed ID: 36223938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological action and clinical outcome of newly developed NSAIDs patch, "LOQOA
    Otsuka N; Yataba I
    Nihon Yakurigaku Zasshi; 2018; 151(5):221-227. PubMed ID: 29760367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical Anti-Inflammatory and Analgesic Effects of Multiple Applications of S(+)-Flurbiprofen Plaster (SFPP) in a Rat Adjuvant-Induced Arthritis Model.
    Sugimoto M; Toda Y; Hori M; Mitani A; Ichihara T; Sekine S; Kaku S; Otsuka N; Matsumoto H
    Drug Dev Res; 2016 Jun; 77(4):206-11. PubMed ID: 27241582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of S-flurbiprofen plaster in the treatment of knee osteoarthritis: a phase II, randomized, double-blind, placebo-controlled, dose-finding study.
    Yataba I; Otsuka N; Matsushita I; Matsumoto H; Hoshino Y
    J Pain Res; 2017; 10():867-880. PubMed ID: 28442928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Flurbiprofen and S-Flurbiprofen Patches on Multimodal Pain Management After Total Knee Arthroplasty: A Prospective Randomized Controlled Trial.
    Tsuji M; Kobayashi N; Yukizawa Y; Oishi T; Takagawa S; Inaba Y
    J Arthroplasty; 2020 Aug; 35(8):2033-2038. PubMed ID: 32362479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic Effect of the Newly Developed S(+)-Flurbiprofen Plaster on Inflammatory Pain in a Rat Adjuvant-Induced Arthritis Model.
    Sugimoto M; Toda Y; Hori M; Mitani A; Ichihara T; Sekine S; Hirose T; Endo H; Futaki N; Kaku S; Otsuka N; Matsumoto H
    Drug Dev Res; 2016 Feb; 77(1):20-8. PubMed ID: 26763139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of tissue pharmacokinetics of esflurbiprofen plaster with flurbiprofen tablets in patients with knee osteoarthritis: A multicenter randomized controlled trial.
    Amemiya M; Nakagawa Y; Yoshimura H; Takahashi T; Inomata K; Nagase T; Ju YJ; Shimaya M; Tsukada S; Hirasawa N; Koga H
    Biopharm Drug Dispos; 2021 Nov; 42(9):418-426. PubMed ID: 34529839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Efficacy of Single Topical NSAID (S-Flurbiprofen Plaster) for Knee Symptoms and Locomotive Dysfunction in Knee Osteoarthritis Patients.
    Sasaki S; Sasaki E; Kimura Y; Naraoka T; Yamamoto Y; Tsuda E; Ishibashi Y
    Prog Rehabil Med; 2021; 6():20210029. PubMed ID: 34316523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and Adherence Rate of S-flurbiprofen Plaster for the Pain Management of Patients With Moderate and End-Stage Knee Osteoarthritis.
    Iguchi M; Takahashi T; Takeshita K
    Cureus; 2023 Sep; 15(9):e44556. PubMed ID: 37662513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic effect of S (+)-flurbiprofen plaster in a rat model of knee arthritis: analysis of gait and synovial fluid prostaglandin E
    Fukumoto A; Tajima K; Hori M; Toda Y; Kaku S; Matsumoto H
    J Pharm Pharmacol; 2018 Jul; 70(7):929-936. PubMed ID: 29607510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-label, long-term safety and tolerability trial of diclofenac sodium 1% gel in patients with knee osteoarthritis.
    Peniston JH; Gold MS; Alwine LK
    Phys Sportsmed; 2011 Sep; 39(3):31-8. PubMed ID: 22030938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of a topical NSAID patch (local action transcutaneous flurbiprofen) and oral diclofenac in the treatment of soft-tissue rheumatism.
    Martens M
    Clin Rheumatol; 1997 Jan; 16(1):25-31. PubMed ID: 9132322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety study.
    Altman RD; Strand V; Hochberg MC; Gibofsky A; Markenson JA; Hopkins WE; Cryer B; Kivitz A; Nezzer J; Imasogie O; Young CL
    Postgrad Med; 2015 Jun; 127(5):517-28. PubMed ID: 25913498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study.
    Karlsson M; Berggren AC
    Clin Ther; 2009 Mar; 31(3):503-13. PubMed ID: 19393841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials and observational studies.
    Zeng C; Wei J; Persson MSM; Sarmanova A; Doherty M; Xie D; Wang Y; Li X; Li J; Long H; Lei G; Zhang W
    Br J Sports Med; 2018 May; 52(10):642-650. PubMed ID: 29436380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.